超声非结构异常胎儿的遗传学异常与临床结局分析
回顾性分析631例因超声非结构异常行产前诊断的孕妇,比较核型分析与SNP-array的检出率。核型异常34例(5.39%),SNP-array异常53例(8.40%),其中致病性CNV 32例。合并≥3个非结构异常时致病性CNV检出率16.67%,显著高于单个异常的4.57%,呈线性上升趋势。
要点
- SNP-array较核型分析可提高超声非结构异常胎儿的遗传学异常检出率。
- 超声非结构异常数目越多,致病性CNV风险越高,≥3个时达16.67%。
- 单一非结构异常中鼻骨发育不良、FGR、NT增厚的致病性CNV检出率相对较高。
核心结论
- SNP-array相对染色体核型分析可能显著提高超声非结构异常胎儿遗传学异常的检出。
- 合并多个超声非结构异常时染色体异常风险呈上升趋势。
研究设计与样本
- 回顾性研究,纳入2016年1月至2019年1月福建省妇幼保健院产前诊断中心631例因超声非结构异常行介入性产前诊断的孕妇。
- 根据孕周采集羊水或脐带血行染色体核型分析和SNP-array,按非结构异常数目分为1个、2个、≥3个三组,组间比较用卡方检验。
主要发现
- 631例中核型异常34例(5.39%,34/631),其中染色体数目异常20例、结构异常14例。
- SNP-array异常53例(8.40%,53/631),包括致病性CNV 32例和VOUS 21例。
- 1个、2个、≥3个非结构异常组的致病性CNV检出率分别为4.57%(21/260)、4.76%(7/147)、16.67%(4/24),差异有统计学意义(χ²=7.419,P<0.05)。
- 单一非结构异常中鼻骨发育不良、FGR、NT增厚的致病性CNV检出率分别为8.11%(3/37)、7.04%(5/71)、5.60%(7/125)。
临床怎么用
- 对超声发现非结构异常的胎儿,在核型分析基础上可考虑SNP-array以提高遗传学异常检出。
- 非结构异常数目越多,应越重视遗传学检测与产前咨询。
局限性
- 本研究为单中心回顾性研究。
- 部分异常组样本量较小(如≥3个非结构异常组仅24例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analysis the incidence of abnormal genetics and the clinical outcome of fetuses with ultrasonic nonstructural abnormality. Methods: This study was conducted retrospectively. 631 pregnant women were enrolled in the Prenatal Diagnostic Center of Fujian Maternal and Child Health Hospital due to ultrasonic nonstructural abnormality from January 2016 to January 2019. According to different gestational weeks, amniotic fluid or umbilical cord blood samples were collected for chromosome karyotype analysis and SNP-array. According to the number of nostructural abnormalities, they were divided into 1 nostructural abnormality group, 2 nostructural abnormalities group, and ≥3 nostructural abnormalities group. Chi-square test was used for comparison between groups. Results: Of the 631 cases, 34 cases (5.4%, 34/631) had abnormal karyotypes, including 20 cases with abnormal chromosome number and 14 cases with abnormal chromosome structure. In results of SNP-array, there were 53 abnormal results (8.4%, 53/631), including 32 cases of pathogenic copy number variations (CNV) and 21 cases of variations of uncertain clinical significance (VOUS). The rates of pathogenic CNV were 4.57% (21/260), 4.76% (7/147) and 16.67% (4/24) in the group of 1, 2 and ≥3 nostructural abnormalities, respectively. The rate of the three groups showed a linear trend, and the difference was statistically significant (χ²=7.419,P<0.05). In the single nostructural abnormality group, the rate of pathogenic CNV of nasal bone dysplasia, fetal growth restriction (FGR) and thickened nuchal translucency (NT) were 8.11% (3/37), 7.04% (5/71) and 5.60% (7/125), respectively. Conclusions: Compared with the karyotype analysis, SNP-array can significantly improve the detection rate of genetic abnormalities in ultrasonic nonstructural abnormality. When multiple ultrasonic nonstructural abnormality were combined, the risk of genetic abnormalities showed an upward trend. 目的: 分析超声非结构异常胎儿的基因组异常发生率,及其对妊娠结局的影响。 方法: 采用回顾性研究,收集2016年1月至2019年1月在福建省妇幼保健院产前诊断中心因超声非结构异常而进行介入性产前诊断的631例孕妇。根据孕周不同抽取羊水标本或脐带血标本进行染色体核型分析及单核苷酸多态性微阵列分析(SNP-array)。按超声非结构异常指标数目分为1个超声非结构异常组、2个超声非结构异常组、≥3个超声非结构异常组,组间比较采用卡方检验。 结果: 染色体核型分析发现异常核型34例(5.39%,34/631),其中染色体数目异常20例,染色体结构异常14例。SNP-array检测发现异常结果53例(8.40%,53/631),包括致病性拷贝数变异(CNV)32例及不明意义变异(VOUS)21例。1个超声非结构异常组、2个超声非结构异常组、≥3个超声非结构异常组致病性CNV 检出率分别为4.57%(21/260)、4.76%(7/147)、16.67%(4/24),其检出率的差异有统计学意义(χ²=7.419,P<0.05)。单一非结构异常组中,鼻骨发育不良、胎儿生长发育受限(FGR)、颈部透明层厚度增厚(NT)的致病性CNV检出率相对较高,分别为 8.11%(3/37)、7.04%(5/71)、5.60%(7/125)。 结论: SNP-array技术相对传统的染色体核型分析,可能显著提高超声非结构异常胎儿遗传学异常的检出。合并多个超声非结构异常时,染色体异常的风险呈上升趋势。.
引用
- Huang HL, Cai MY, Lin N, et al. [Analysis of genetic abnormalities and clinical outcome of fetus with ultrasonic nonstructural abnormality]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021. PMID: 34619927. doi:10.3760/cma.j.cn112150-20210326-00307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。